Unibest 优贝德
← Back to patent-cliff list

CAS 123-08-0

4-hydroxybenzaldehyde

CodesPIMAV-001、SAFI-002、FEBU-016

Application context (from source-drug indications)

妄想酒石酸匹莫范色林幻觉酒石酸匹莫范色林帕金森病甲磺酸沙非胺疼痛甲磺酸沙非胺药物性运动障碍甲磺酸沙非胺肝功能衰退甲磺酸沙非胺多系统萎缩甲磺酸沙非胺肾功能不全甲磺酸沙非胺高尿酸血症非布司他痛风非布司他颅内出血非布司他溃疡性结肠炎非布司他慢性肾功能不全非布司他疼痛非布司他

Source drugs (routes using this intermediate)

DrugTierExpiry
酒石酸匹莫范色林Pimavanserin TartrateTier C — Watch / trade2029
甲磺酸沙非胺Safinamide MesylateTier C — Watch / trade-
非布司他FebuxostatTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Qualified Partner — East China API WorksEthyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP SiteEthyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Pharmaceutical Intermediates
询价询价询价

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.